)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Monivent
Monivent (MONI) investor relations material
Monivent Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary26 Aug, 2026
Executive summary
MDR approval process advanced as planned, with all BSI follow-up questions addressed and final review pending; launch with Dräger targeted for H2 2026.
Directed share issues provided SEK 10.4 million in new capital and converted SEK 8 million bridge loan, restoring equity and resolving the control balance situation.
Focus shifted to commercialization and market preparation, with ongoing marketing activities and product demonstrations across Europe.
Financial highlights
Q2 2026 net sales: SEK 287k (up from SEK 177k in Q2 2025); H1 2026 net sales: SEK 565k (down from SEK 845k in H1 2025).
Q2 2026 EBIT: SEK -2,577k (Q2 2025: SEK -2,146k); H1 2026 EBIT: SEK -5,116k (H1 2025: SEK -4,319k).
Cash at period end: SEK 23k (Q2 2025: SEK 2,422k); equity ratio: 63%.
Q2 2026 total operating income: SEK 1,099k (Q2 2025: SEK 1,578k); H1 2026: SEK 2,140k (H1 2025: SEK 2,367k).
Outlook and guidance
MDR approval and European launch with Dräger expected in H2 2026; FDA 510(k) submission planned in coming months.
New capital expected to fund operations until cash flow positive by end of 2028, contingent on full exercise of warrants.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Monivent
- Sales fell and losses deepened as regulatory and financing efforts remain in focus.MONI
Q1 2026 - Improved EBIT and regulatory advances set the stage for a key product launch in 2026.MONIQ4 2025
- Sales fell on regulatory delays, but liquidity and patent position were strengthened.MONIQ3 2025
- Revenue guidance cut as sales lag and capital need grows amid delayed product launches.MONIQ2 2025
- Sales fell and losses narrowed as Monivent pivots to global partnerships and secures new financing.MONIQ3 2024
- Regulatory advances and a global distribution deal position Monivent for commercial expansion.MONIQ2 2024
- Q1 sales up 45% and EBIT loss narrowed, with global expansion underway via new partnerships.MONIQ1 2025
- Breakthrough year with Dräger deal and funding sets Monivent on path to global expansion.MONIQ4 2024
Next Monivent earnings date
Q3 202618 Nov, 2026
Monivent
Next Monivent earnings date
Q3 202618 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Monivent develops and provides medical devices designed to support neonatal respiratory care. The company focuses on creating innovative solutions that assist healthcare professionals in monitoring and optimizing ventilation for newborns. Its technologies aim to improve patient outcomes by enhancing precision and safety in critical care settings. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq Stockholm.